Vero, Vittoria
 Distribuzione geografica
Continente #
EU - Europa 921
NA - Nord America 771
AS - Asia 264
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 1.963
Nazione #
US - Stati Uniti d'America 765
DE - Germania 474
SE - Svezia 155
CN - Cina 115
UA - Ucraina 92
SG - Singapore 79
IE - Irlanda 43
IT - Italia 38
FI - Finlandia 31
FR - Francia 28
ID - Indonesia 27
GB - Regno Unito 23
RU - Federazione Russa 20
TR - Turchia 19
IN - India 11
IR - Iran 8
BE - Belgio 5
JP - Giappone 5
CA - Canada 4
CH - Svizzera 4
RO - Romania 4
AU - Australia 2
LT - Lituania 2
RE - Reunion 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BZ - Belize 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EU - Europa 1
HR - Croazia 1
MX - Messico 1
Totale 1.963
Città #
Chandler 153
Ashburn 85
Singapore 65
Jacksonville 57
Dublin 42
San Mateo 39
Nanjing 37
Chicago 36
Jakarta 27
Nürnberg 27
Dearborn 24
Wilmington 23
Munich 21
Boston 20
Izmir 19
Marseille 19
New York 17
Milan 15
Ann Arbor 14
Helsinki 14
Houston 13
Princeton 13
Nanchang 12
Moscow 11
Woodbridge 9
Redwood City 8
Washington 7
Beijing 6
Detroit 6
Mountain View 6
Norwalk 6
San Diego 6
University Park 6
Bremen 5
Brussels 5
Hebei 5
Kunming 5
Lawrence 5
Los Angeles 5
San Jose 5
Seattle 5
Shenyang 5
Tabriz 5
Changsha 4
Fairfield 4
Fremont 4
Guangzhou 4
Hefei 4
Portland 4
Tianjin 4
Boardman 3
Jiaxing 3
Jinan 3
Nuremberg 3
Ottawa 3
Phoenix 3
Zurich 3
Andover 2
Cattolica 2
Clayton 2
Como 2
Hangzhou 2
Kish 2
Leawood 2
Ningbo 2
Orangeburg 2
Saint-Pierre 2
Shanghai 2
Simi Valley 2
Verona 2
Abidjan 1
Adliswil 1
Ardabil 1
Belize City 1
Bologna 1
Boydton 1
Brno 1
Busto Arsizio 1
Chengdu 1
Costa Mesa 1
Dalmine 1
Garza García 1
Gunzenhausen 1
Indiana 1
Jian 1
Lanzhou 1
London 1
Markdorf 1
Perugia 1
Philadelphia 1
Pune 1
Rome 1
Sacramento 1
Saint Louis 1
Serra Pedace 1
Shaoxing 1
Sibiu 1
Taizhou 1
Thornhill 1
Tokyo 1
Totale 1.018
Nome #
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 160
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 157
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 145
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?] 119
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 113
[The treatment of hepatocellular carcinoma: an update] 106
gastroesophageal reflux disease: facts and uncertaines 104
-Fatty liver and drugs 102
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 100
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 100
-Nonalcoholic fatty liver disease: defining a common problem 87
The EFSA health claims 'learning experience' 81
Braised liver with herbs: the risks of naturopathic hepatoprotection. 80
Severe acute hepatitis after resumption of interferon-Beta therapy for multiple sclerosis: a word of caution. 79
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 72
Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH) 69
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 60
-The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis. 58
Genetic and environmental factors responsible for oxidative stress in now alcoholic fatty liver disease (NAFLD) 28
Intestinal permeability in nonalcoholic fatty liver disease (NAFLD) 26
A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 23
PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND METABOLIC SYNDROME IN PATIENTS WITH PSORIASIS 23
SERUM SODIUM IS A PREDICTOR OF SURVIVAL FOR "INTERMEDIATE HCC" TREATED WITH TRANSARTERIAL CHEMIOEMBOLIZATION (TACE) 22
Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease. 21
Body composition and nutrient utilisation in patients with non-alcoholic steato-hepatitis (NASH) 20
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 19
Colon diverticular disease 4
Totale 1.978
Categoria #
all - tutte 8.144
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.144


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020163 0 0 0 0 22 34 29 8 14 16 15 25
2020/2021166 6 19 1 18 30 7 17 1 30 0 27 10
2021/2022179 4 24 1 18 11 4 2 26 5 7 40 37
2022/2023477 44 57 29 60 43 55 29 40 64 31 16 9
2023/2024259 13 69 10 18 26 39 2 21 1 15 28 17
2024/202597 4 12 36 5 40 0 0 0 0 0 0 0
Totale 1.978